Tuberc Respir Dis > Epub ahead of print
DOI: https://doi.org/10.4046/trd.2024.0120    [Epub ahead of print]
Published online August 30, 2024.
Disease Severity and Activity in Bronchiectasis: A Paradigm Shift in Bronchiectasis Management
Yunjoo Im, M.D., Ph.D.1  , James D. Chalmers, M.B.Ch.B., Ph.D.2, Hayoung Choi, M.D., Ph.D.3 
1Division of Pulmonology and Allergy, Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Republic of Korea
2Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom
3Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Republic of Korea
Correspondence:  Hayoung Choi,
Email: hychoimd@gmail.com
Received: 11 August 2024   • Accepted: 26 August 2024
Abstract
Bronchiectasis has an increasing prevalence and substantial clinical and economic burden. Therefore, physicians should identify patients with bronchiectasis at high risk of disease progression to ensure optimal management in advance. The heterogeneity of bronchiectasis means it is unlikely that any single parameter could identify highrisk patients; therefore, disease severity is usually assessed using validated composite tools, such as the Bronchiectasis Severity Index, FACED, and Bronchiectasis Aetiology Comorbidity Index, to predict long-term outcomes in bronchiectasis. Disease severity, however, implies an advanced process with lung destruction. Earlier intervention may prevent disease progression and improve outcomes. To identify patients at risk, rather than patients with established advanced disease, we need to shift our focus from disease severity to disease activity. Disease activity denotes the activation level of underlying pathophysiological processes and can be measured using clinical presentations and biomarkers. This review discusses a paradigm shift in bronchiectasis management, focusing on disease activity rather than severity, to prevent disease progression.
Key Words: Bronchiectasis, Severity of Illness Index, Inflammation, Disease Progression
TOOLS
METRICS Graph View
  • 0 Crossref
  •   Scopus
  • 1,146 View
  • 146 Download
ORCID iDs

Yunjoo Im
https://orcid.org/0000-0002-0892-334X

Hayoung Choi
https://orcid.org/0000-0003-4812-0653

Related articles


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next